Yeah.

It's really insightful.

You know, there's different, different parts of the ecosystem here, um, which, you know, it, it takes some time to really digest.

Like there's, there's our pharmacy partners, um, there's the clinics that, that give the patient, um, our drug when they, when they're prescribed it, and then there's, you know, referring psy- uh, psychiatrists around the country.

So really understanding how the ecosystem of the, of the drugs actually makes it into a patient and us as a manufacturer and how, you know, how we are able to supply them.

You know, we worked, um, the TGA, which is the FDA or the Health Canada equivalent of, of Australia, uh, making sure that our products actually fit a certain spec and they were allowed to be brought into the country, um, pharmaceutical-grade products and that's, um...

You know, we're seeing now that we started, you know, earlier this year, we were in 10 clinics, now we're in 26.

... applications, all that.